In the present study, through a detailed phenotypic analysis, we show that HIPs are not better than conventional islet epitopes in eliciting IFN-γ, IL-10, or IL-17 specific T cell responses in both patients with type 1 diabetes and high-risk unaffected family members. The gene discussed is IL17A; the disease is type 1 diabetes mellitus.